Sarah James
Stock Analyst at Cantor Fitzgerald
(1.98)
# 3,145
Out of 5,241 analysts
317
Total ratings
34.05%
Success rate
-6.96%
Average return
Main Sectors:
Stocks Rated by Sarah James
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MOH Molina Healthcare | Maintains: Neutral | $144 → $209 | $184.99 | +12.98% | 16 | May 11, 2026 | |
| DCGO DocGo | Suspends: Overweight | n/a | $0.57 | - | 10 | May 11, 2026 | |
| HCAT Health Catalyst | Suspends: Neutral | n/a | $1.19 | - | 10 | May 11, 2026 | |
| CI The Cigna Group | Maintains: Overweight | $325 → $340 | $285.27 | +19.19% | 23 | May 1, 2026 | |
| ACHC Acadia Healthcare Company | Maintains: Neutral | $20 → $30 | $25.81 | +16.23% | 19 | May 1, 2026 | |
| CNC Centene | Upgrades: Overweight | $41 → $60 | $58.27 | +2.97% | 18 | Apr 29, 2026 | |
| UHS Universal Health Services | Maintains: Neutral | $229 → $194 | $168.64 | +15.04% | 29 | Apr 29, 2026 | |
| TBRG TruBridge | Downgrades: Neutral | $25 → $26 | $25.86 | +1.51% | 7 | Apr 24, 2026 | |
| NYXH Nyxoah | Reiterates: Overweight | $11 | $3.08 | +257.14% | 1 | Mar 23, 2026 | |
| MDXG MiMedx Group | Maintains: Overweight | $12 → $8 | $3.57 | +124.40% | 1 | Feb 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $290 → $201 | $305.12 | -34.12% | 22 | Feb 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $525 → $588 | $423.00 | +39.01% | 22 | Jan 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $78 → $95 | $95.89 | -0.93% | 16 | Oct 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $190 → $245 | $196.66 | +24.58% | 23 | Oct 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $36 | $13.95 | +158.06% | 13 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $440 | $393.85 | +11.72% | 18 | Aug 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $26 → $28 | $23.25 | +20.43% | 15 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $485 | $392.68 | +23.51% | 20 | Apr 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $15 | $4.33 | +246.42% | 11 | Mar 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $10 | $6.36 | +57.23% | 2 | Aug 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Equal-Weight | $133 | $199.74 | -33.41% | 6 | Mar 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $42 | $21.40 | +96.26% | 3 | Aug 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $6 → $5 | $7.12 | -29.78% | 2 | Sep 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $7 → $5 | $7.72 | -35.23% | 2 | Aug 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $14 → $21 | $15.73 | +33.50% | 3 | Aug 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $39 | $52.39 | -25.56% | 1 | Aug 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $193 | $72.72 | +165.40% | 2 | Sep 15, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | n/a | $2.82 | - | 2 | Mar 1, 2017 |
Molina Healthcare
May 11, 2026
Maintains: Neutral
Price Target: $144 → $209
Current: $184.99
Upside: +12.98%
DocGo
May 11, 2026
Suspends: Overweight
Price Target: n/a
Current: $0.57
Upside: -
Health Catalyst
May 11, 2026
Suspends: Neutral
Price Target: n/a
Current: $1.19
Upside: -
The Cigna Group
May 1, 2026
Maintains: Overweight
Price Target: $325 → $340
Current: $285.27
Upside: +19.19%
Acadia Healthcare Company
May 1, 2026
Maintains: Neutral
Price Target: $20 → $30
Current: $25.81
Upside: +16.23%
Centene
Apr 29, 2026
Upgrades: Overweight
Price Target: $41 → $60
Current: $58.27
Upside: +2.97%
Universal Health Services
Apr 29, 2026
Maintains: Neutral
Price Target: $229 → $194
Current: $168.64
Upside: +15.04%
TruBridge
Apr 24, 2026
Downgrades: Neutral
Price Target: $25 → $26
Current: $25.86
Upside: +1.51%
Nyxoah
Mar 23, 2026
Reiterates: Overweight
Price Target: $11
Current: $3.08
Upside: +257.14%
MiMedx Group
Feb 17, 2026
Maintains: Overweight
Price Target: $12 → $8
Current: $3.57
Upside: +124.40%
Feb 12, 2026
Maintains: Neutral
Price Target: $290 → $201
Current: $305.12
Upside: -34.12%
Jan 28, 2026
Maintains: Overweight
Price Target: $525 → $588
Current: $423.00
Upside: +39.01%
Oct 30, 2025
Maintains: Overweight
Price Target: $78 → $95
Current: $95.89
Upside: -0.93%
Oct 29, 2025
Maintains: Overweight
Price Target: $190 → $245
Current: $196.66
Upside: +24.58%
Oct 7, 2025
Reiterates: Overweight
Price Target: $36
Current: $13.95
Upside: +158.06%
Aug 26, 2025
Reiterates: Overweight
Price Target: $440
Current: $393.85
Upside: +11.72%
Aug 8, 2025
Maintains: Overweight
Price Target: $26 → $28
Current: $23.25
Upside: +20.43%
Apr 23, 2025
Reiterates: Overweight
Price Target: $485
Current: $392.68
Upside: +23.51%
Mar 11, 2025
Reiterates: Overweight
Price Target: $15
Current: $4.33
Upside: +246.42%
Aug 20, 2024
Reiterates: Overweight
Price Target: $10
Current: $6.36
Upside: +57.23%
Mar 6, 2024
Initiates: Equal-Weight
Price Target: $133
Current: $199.74
Upside: -33.41%
Aug 22, 2023
Reiterates: Overweight
Price Target: $42
Current: $21.40
Upside: +96.26%
Sep 15, 2022
Maintains: Equal-Weight
Price Target: $6 → $5
Current: $7.12
Upside: -29.78%
Aug 19, 2022
Maintains: Overweight
Price Target: $7 → $5
Current: $7.72
Upside: -35.23%
Aug 8, 2022
Maintains: Overweight
Price Target: $14 → $21
Current: $15.73
Upside: +33.50%
Aug 12, 2021
Initiates: Overweight
Price Target: $39
Current: $52.39
Upside: -25.56%
Sep 15, 2017
Upgrades: Overweight
Price Target: $193
Current: $72.72
Upside: +165.40%
Mar 1, 2017
Downgrades: Underweight
Price Target: n/a
Current: $2.82
Upside: -